On day 4 post-treatment, tumor tissue sections were analyzed using immunofluorescence microscopy for immune cell markers such as CD3, CD4, and CD8 for the assessment of the level of infiltrating T cells in the tumor tissues (Fig. 3a and b). The gene discussed is CD8A; the disease is neoplasm.